125 trends tracked about this subject — the full history, oldest to newest below.
Recent studies link popular GLP-1 weight-loss drugs to unexpected dermatological side effects like nail detachment and hair loss.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage links GLP-1 medications like Ozempic and Wegovy to legal action involving vision loss alongside contrasting studies.
A growing wave of coverage examines newly reported links between popular GLP-1 medications and rare instances of severe vision loss.
Recent reporting examines whether GLP-1 weight-loss medications could help women conceive and boost fertility outcomes.
Popular weight loss medications face new scrutiny as coverage connects them to unusual nail and hair complications.
Recent studies indicate that popular GLP-1 weight-loss medications like Ozempic and Mounjaro may also slow biological aging.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines the phenomenon of 'Ozempic babies' and the broader relationship between GLP-1 drugs and women's health.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link popular GLP-1 weight-loss drugs to surprising physical side effects including hair loss and nail troubles.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies link weight-loss medications like Ozempic and Wegovy to unexpected hair and nail side effects.
A Massachusetts man's lawsuit alleging permanent blindness from Ozempic highlights growing legal and medical concerns over GLP-1 weight loss drugs.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
McDonald's is reshaping its menu offerings to adapt to changing consumer habits and the rise of GLP-1 weight-loss drugs.
Over one million Americans are now taking GLP-1 medications without a documented diagnosis of diabetes or obesity, according to recent reports.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GLP-1 users express intense anger as employers begin dropping insurance benefits for the sought-after medications.
Prescriptions for GLP-1 drugs like Ozempic among Americans without medical needs are surging across multiple demographic groups.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
New reports warn that discontinuing GLP-1 weight-loss medications like Ozempic, Mounjaro, and Wegovy may increase the risk of heart attack and stroke.
Major drugmakers Novo Nordisk and Eli Lilly face numerous lawsuits alleging popular GLP-1 medications cause sudden vision loss.
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A large genetic study connects GLP-1 receptor activation to improved mental well-being.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines rapid weight regain after discontinuing GLP-1 medications like Ozempic, semaglutide, and tirzepatide.
GLP-1 medications face growing attention for unexpected health benefits and wider usage trends beyond weight management.
Medical experts and journalists are working to distinguish scientific facts from social media hype regarding side effects of GLP-1 weight loss medications.
New research indicates that GLP-1 medications like Ozempic and Wegovy may significantly reduce the frequency of asthma attacks and COPD flare-ups.
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
Growing concerns emerge over the 'Ozempidemic' as users report intense cravings and safety risks associated with GLP-1 weight-loss medications.
New reports suggest popular GLP‑1 weight‑loss drugs may trigger male pattern baldness, sparking medical and public‑interest scrutiny.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies indicate that GLP-1 weight loss medications may worsen or accelerate hair loss in men.
A growing cultural and medical debate is emerging over the use of GLP-1 medications, focusing on the tension between clinical benefits and social stigma.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Experts call for safer weight loss methods as public and medical attention intensifies around the use and effectiveness of GLP-1 medications.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Ozempic, a popular weight‑loss drug, is now being linked to benefits for serious mental illnesses such as bipolar disorder.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.
New scientific discoveries regarding brain circuits may redefine the understood mechanism of GLP-1 weight loss drugs like Ozempic and Wegovy.
Researchers are investigating unexpected health benefits of GLP-1 medications as the drugs evolve beyond their primary use for weight loss.
The Department of Veterans Affairs is launching a study to determine if GLP-1 medications can be used to treat alcohol use disorder in veterans.